Primary lymphoedema

Gene: ZNHIT3

Amber List (moderate evidence)

ZNHIT3 (zinc finger HIT-type containing 3)
EnsemblGeneIds (GRCh38): ENSG00000273611
EnsemblGeneIds (GRCh37): ENSG00000108278
OMIM: 604500, Gene2Phenotype
ZNHIT3 is in 6 panels

2 reviews

Ida Ertmanska (Genomics England Curator)

Green List (high evidence)

Comment on list classification: There are now 2 unrelated probands reported with biallelic missense variants in ZNHIT3 and PEHO syndrome, including oedema. A supportive znhit3 knockdown model in zebrafish showed a syndromic presentation with pericardiac oedema. Hence, this gene can be promoted to Green at the next update.
Created: 14 Aug 2026, 2:19 p.m. | Last Modified: 14 Aug 2026, 2:19 p.m.
Panel Version: 5.7
PMID: 39252897 Rahman et al., 2024 - PRE-PRINT
Family with 2 fetal cases with isolated hydrops. Both individuals comp het for ZNHIT3 c.40T>C p.Cys14Arg & c.251_254delAAGA variants.
Functional evidence: overexpression of previously reported pathogenic ZNHIT3 variants in HEK293T cells decreases the translational output significantly relative to WT control cells.

PMID: 31048081 Õunap et al., 2019
Report of a female patient (Estonian) with Progressive Encephalopathy with Edema, Hypsarrhythmia, and Optic atrophy (PEHO) syndrome and comp het ZNHIT3 variants c.92C>T p.(Ser31Leu) & c.41G>T p.(Cys14Phe). Variant p.(Cys14Phe) has 52 alleles reported in gnomAD v4.1.1 (no homozygotes). Unaffected parents het for a variant each.
She had severe muscular hypotonia, profound developmental delay, seizures (onset at 10 months), hypotonia, feeding difficulties, limb edema, and absent visual fixation, diagnosed with blindness at 17 months (pale and small disks, and temporal disk pallor noted). Progressive microcephaly also noted: OFC -0.5 SD at birth, OFC 46.5 cm (−2.5SD) at 3.5 yrs, and OFC 47 cm (−4 SD) and 8.5 yrs.

PMID: 28335020 Anttonen et al., 2017
Study of 23 Finnish individuals with PEHO syndrome, as well as 40 Finnish and 47 non-Finnish patients with PEHO-like features.
All patients were homozygous for a ZNHIT3:c.92C>T, p.Ser31Leu (NM_004773.4) variant - present in gnomAD 4.1.1 at MAF= 0.004411 in the Finnish population, however no homozygotes reported.
Shared patient phenotype: progressive cerebellar atrophy, microcephaly at birth (severity not stated), optic atrophy, limb oedema, hypotonia, infantile spasms with hypsarrhythmia, profound motor and intellectual disability.

Functional: morpholino knockdown of znhit3 in zebrafish resulted in microcephaly, structural cerebellar anomalies and pericardiac oedema. These phenotypes were rescued by co-injection of human WT ZNHIT3 mRNA. Overexpression of WT or p.Ser31Leu - bearing human ZNHIT3 mRNA did not induce any defects. Hence, authors pose p.Ser31Leu is a LoF variant.

FUNCTIONAL EVIDENCE:
PMID: 40178020 Yang, Xin, and Dean, 2025 - CRISPR/Cas9 used to create a mouse znhit3 -/- knockout model. Absence of ZNHIT3 led to decreased snoRNA and rRNA abundance which causes defects of ribosomes and mRNA splicing. Microinjection of Znhit3 cRNA partially rescues the phenotype and confirms that ZNHIT3 is required for mRNA translation during preimplantation development.
Created: 14 Aug 2026, 2:04 p.m. | Last Modified: 14 Aug 2026, 2:04 p.m.
Panel Version: 5.3

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
PEHO syndrome, OMIM:260565; PEHO syndrome, MONDO:0009841

Publications

Rebecca Foulger (Genomics England curator)

Added 'founder-effect' tag based on PMID:28335020, and S31L variant found in patients in the Finnish population.
Created: 15 Aug 2017, 10:55 a.m.
Comment on list classification: Kept rating as red: only 1 reported variant to-date in a single population (PMID:28335020) and not yet classified in DD-G2P.
Created: 15 Aug 2017, 10:54 a.m.
In 24 patients of Finnish descent with PEHO syndrome (MIM:260565), Anttonen et al. (2017, PMID:28335020) identified a homozygous missense mutation in the ZNHIT3 gene (S31L).
Created: 15 Aug 2017, 10:51 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
PEHO syndrome, 260565

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
  • Other
Phenotypes
  • PEHO syndrome, OMIM:260565
  • PEHO syndrome, MONDO:0009841
Tags
founder-effect Q3_26_promote_green
OMIM
604500
Clinvar variants
Variants in ZNHIT3
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

14 Aug 2026, Gel status: 2

Entity classified by Genomics England curator

Ida Ertmanska (Genomics England Curator)

Gene: znhit3 has been classified as Amber List (Moderate Evidence).

14 Aug 2026, Gel status: 2

Added Tag

Ida Ertmanska (Genomics England Curator)

Tag Q3_26_promote_green tag was added to gene: ZNHIT3.

14 Aug 2026, Gel status: 2

Entity classified by Genomics England curator

Ida Ertmanska (Genomics England Curator)

Gene: znhit3 has been classified as Amber List (Moderate Evidence).

14 Aug 2026, Gel status: 1

Set Phenotypes

Ida Ertmanska (Genomics England Curator)

Phenotypes for gene: ZNHIT3 were changed from PEHO syndrome, 260565 to PEHO syndrome, OMIM:260565; PEHO syndrome, MONDO:0009841

14 Aug 2026, Gel status: 1

Set publications

Ida Ertmanska (Genomics England Curator)

Publications for gene: ZNHIT3 were set to 28335020

15 Aug 2017, Gel status: 1

Gene classified by Genomics England curator

Rebecca Foulger (Genomics England curator)

This gene has been classified as Red List (Low Evidence).

15 Aug 2017, Gel status: 0

Added New Source

Rebecca Foulger (Genomics England curator)

ZNHIT3 was added to Lymphatic Disorderspanel. Sources: Other

15 Aug 2017, Gel status: 0

Created

Rebecca Foulger (Genomics England curator)

ZNHIT3 was created by rfoulger